How to Get Testosterone Enanthate in Washington

Washington State Prescribing Rules for Testosterone Enanthate

Testosterone enanthate is a Schedule III controlled substance under both federal and Washington state law. Any prescriber in Washington with a valid DEA registration and active state license may prescribe it for male hypogonadism. This includes physicians (MD/DO), nurse practitioners, and physician assistants with prescriptive authority granted by the Washington State Department of Health.

Washington adopted broad telehealth parity legislation (RCW 48.43.735) that requires commercial insurers to cover telehealth visits at the same rate as in-person encounters. The Washington Medical Commission permits controlled substance prescriptions through telehealth when a valid provider-patient relationship is established, which can now occur via an audio-video visit without a prior in-person meeting [1]. The Ryan Haight Act's federal telehealth flexibilities, extended through DEA rulemaking in 2025, continue to allow Schedule III prescriptions after a video evaluation [2].

A prescriber must document two morning serum testosterone levels below 300 ng/dL (or below the lab's reference range) on separate days before initiating therapy, per Endocrine Society guidelines published in the Journal of Clinical Endocrinology & Metabolism [3]. Washington does not impose additional state-level diagnostic criteria beyond standard medical practice requirements.

One practical note: Washington requires e-prescribing for controlled substances under SB 5380, which took effect January 2021. Your provider must transmit the testosterone enanthate prescription electronically to the pharmacy. Paper prescriptions are permitted only in specific exempted situations (technical failure, veterinary use, or certain compounding scenarios).

Required Labs Before Starting Testosterone Enanthate

The lab panel must confirm hypogonadism and screen for contraindications before a single dose leaves the vial. Endocrine Society guidelines recommend the following baseline workup [3]:

Mandatory labs:

• Total testosterone (drawn between 7:00 and 10:00 AM, fasting preferred)
• A second confirmatory total testosterone on a separate day
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to differentiate primary from secondary hypogonadism
• Complete blood count (CBC) with hematocrit
• Prostate-specific antigen (PSA) for men over 40
• Comprehensive metabolic panel

Recommended additional labs:

• Free testosterone or sex hormone-binding globulin (SHBG)
• Prolactin (if total testosterone is <150 ng/dL or secondary hypogonadism is suspected)
• Lipid panel
• Hemoglobin A1c or fasting glucose

Quest Diagnostics and Labcorp both operate draw sites across Washington, from Seattle and Tacoma to Spokane and the Tri-Cities. Many telehealth TRT providers will send a lab requisition to a location near you within 24 hours of your initial intake. Results typically return in 2 to 3 business days.

The T-Trials, a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine (N=790 men aged 65 and older with testosterone <275 ng/dL), demonstrated that one year of testosterone gel improved sexual function, physical activity, and mood compared to placebo [4]. These trials reinforced the importance of confirming low testosterone with standardized morning draws before treatment, a principle that applies equally to enanthate injections.

Telehealth Testosterone Enanthate Providers Serving Washington

Telehealth TRT has expanded rapidly in Washington since 2020. Licensed providers conduct a video consultation, review your lab results, and (if clinically appropriate) e-prescribe testosterone enanthate to a pharmacy of your choice the same day.

The American Urological Association's 2018 guidelines state: "Testosterone therapy should be offered to men with symptomatic testosterone deficiency to induce and maintain secondary sex characteristics and to improve sexual function, sense of well-being, muscle mass and strength, and bone mineral density" [5]. Washington-licensed telehealth providers follow these indications when evaluating candidates for enanthate therapy.

Dr. Shalender Bhasin, the lead investigator of the T-Trials and professor at Brigham and Women's Hospital, has noted: "The evidence supports testosterone treatment in men who have unequivocally low testosterone levels and symptoms consistent with androgen deficiency, regardless of the clinical setting in which therapy is initiated" [4]. This position supports the validity of telehealth-initiated TRT when proper diagnostic criteria are met.

When selecting a telehealth provider in Washington, verify three things. First, confirm the prescriber holds an active Washington state license (searchable at the DOH provider credential search). Second, confirm they require lab work before prescribing. Third, confirm they schedule follow-up labs at 3 months and then every 6 to 12 months, per Endocrine Society monitoring recommendations [3]. Providers who skip labs or prescribe testosterone to men with normal levels fall outside guideline-concordant care.

Typical telehealth consultation costs in Washington range from $99 to $199 for an initial visit, with follow-up visits between $75 and $150. These fees are separate from the cost of testosterone enanthate itself, which varies by pharmacy.

Pharmacy Options and 503A Compounding in Washington

Washington patients can fill a testosterone enanthate prescription at three types of pharmacies: national retail chains, independent retail pharmacies, and 503A compounding pharmacies licensed by the Washington State Pharmacy Quality Assurance Commission.

Retail pharmacy pricing. Brand-name testosterone enanthate (Delatestryl) is rarely stocked; most retail pharmacies dispense generic testosterone enanthate manufactured by Perrigo, Hikma, or Sun Pharma. A 5 mL vial of 200 mg/mL (providing roughly 4 to 5 weekly doses of 200 mg) costs $40 to $90 without insurance at most Washington retail pharmacies. GoodRx and similar discount programs can reduce cash-pay prices to $30 to $50 for a single vial in the Seattle metro area.

503A compounding pharmacies. Washington permits state-licensed 503A compounding pharmacies to prepare testosterone enanthate in custom concentrations or volumes based on a patient-specific prescription [6]. These pharmacies may also ship directly to patients within Washington. A compounded 10 mL vial of testosterone enanthate 200 mg/mL typically costs $50 to $120 depending on the pharmacy and carrier oil used (grapeseed or cottonseed). Compounding is useful for patients who need non-standard concentrations, alternative carrier oils due to allergies, or larger multi-dose vials.

The FDA's guidance on 503A compounding requires that the pharmacy operates under a valid prescription for an individually identified patient and does not produce copies of commercially available drugs in standard formulations unless a clinical reason (documented allergy, need for a specific concentration) justifies compounding [6]. Most testosterone enanthate compounding in practice involves concentration or volume customizations that meet this standard.

Out-of-state pharmacy transfers. You can transfer a testosterone enanthate prescription from another state to a Washington pharmacy, but the process depends on the original state's transfer laws and whether the medication is a controlled substance. Washington allows one transfer of a Schedule III prescription between pharmacies, and some states allow electronic transfer. Coordinate with both the sending and receiving pharmacies to confirm timelines, as controlled substance transfers can take 48 to 72 hours.

Washington Medicaid and Insurance Coverage

Washington Apple Health (Medicaid) covers testosterone enanthate for the indication of male hypogonadism. Coverage requires prior authorization (PA) through the state's preferred drug list managed by the Washington Health Care Authority [7].

Prior authorization documentation requirements:

• Two morning serum total testosterone levels below the lab's reference range (typically <300 ng/dL)
• Documentation of symptoms consistent with hypogonadism (fatigue, decreased libido, erectile dysfunction, loss of muscle mass, depressed mood)
• Confirmation that secondary causes have been evaluated (pituitary imaging if LH/FSH are low, prolactin level, medication review)
• Attestation that the patient does not have contraindications: breast or prostate cancer, untreated polycythemia (hematocrit >54%), untreated severe obstructive sleep apnea, uncontrolled heart failure, or desire for near-term fertility

PA decisions are typically returned within 2 to 5 business days. If denied, the prescriber can submit a clinical appeal with supporting chart notes and lab results.

Commercial insurers in Washington (Premera, Regence, Molina, Kaiser Permanente of Washington, Coordinated Care) generally cover generic testosterone enanthate on formulary tier 2 or 3. Copays range from $10 to $45 per fill depending on the plan. Some plans require step therapy, meaning the patient must try a lower-cost formulation (such as testosterone cypionate) before enanthate is approved, though in practice these two esters are often considered interchangeable and most plans cover both without restriction.

A 2020 analysis in Urology reported that the average annual out-of-pocket cost for injectable testosterone (enanthate or cypionate) among commercially insured men was $120 to $360, compared with $1,800 to $6,000 for topical testosterone gels [8]. This cost differential makes injectable testosterone enanthate one of the most affordable TRT options for Washington patients.

Dosing, Administration, and Monitoring Schedule

The FDA-approved testosterone enanthate label recommends doses of 50 to 400 mg intramuscularly every 2 to 4 weeks for male hypogonadism [9]. In current clinical practice, most TRT providers prescribe 100 to 200 mg weekly or split into twice-weekly injections of 50 to 100 mg to maintain more stable serum levels and reduce hematocrit spikes.

A pharmacokinetic study published in the Journal of Clinical Endocrinology & Metabolism showed that weekly injections of testosterone enanthate 100 mg produced steady-state trough levels of 500 to 700 ng/dL with peak-to-trough fluctuations of approximately 30%, whereas biweekly 200 mg injections produced fluctuations exceeding 60% [10]. The more frequent dosing schedule reduces the "roller coaster" effect that patients commonly report with every-two-week protocols.

Monitoring timeline per Endocrine Society guidelines [3]:

• 3 months after initiation: total testosterone (trough, drawn the morning before the next injection), CBC with hematocrit, PSA, liver function
• 6 months: symptom reassessment, testosterone level, hematocrit
• 12 months: full lab panel (testosterone, CBC, PSA, lipids, metabolic panel), bone density if osteoporosis was present at baseline
• Annually thereafter: testosterone, hematocrit, PSA, lipid panel

The most common safety signal during TRT is erythrocytosis. The T-Trials observed that hematocrit exceeded 54% in approximately 5% of men receiving testosterone versus 1% on placebo [4]. If hematocrit exceeds 54%, the Endocrine Society recommends dose reduction, switching to a shorter-acting ester or topical, or therapeutic phlebotomy [3]. Washington Blood Works (Bloodworks Northwest) accepts therapeutic phlebotomy donations at centers across the Puget Sound region, which provides a convenient option for patients who develop polycythemia on TRT.

Timeline from Consult to First Injection in Washington

Most patients can complete the process in 7 to 14 days. Here is the typical sequence:

Day 1: Complete an online intake form or schedule a telehealth or in-person visit. The provider sends a lab requisition.

Days 2 to 4: Visit a lab draw site (Quest, Labcorp, or a local hospital lab). Arrive fasting, before 10:00 AM.

Days 4 to 7: Lab results return. The provider reviews results, conducts a video or in-person consultation, and (if criteria are met) e-prescribes testosterone enanthate.

Days 7 to 10: The pharmacy fills the prescription. Retail pharmacies typically have testosterone enanthate in stock and can fill same-day or next-day. Compounding pharmacies may require 3 to 5 business days for preparation and shipping.

Days 10 to 14: You receive the medication and perform (or receive) your first injection. Many providers offer injection training via video call for patients new to self-administration.

Patients transferring an existing prescription to a Washington pharmacy can often shave 3 to 5 days off this timeline since they already have qualifying lab work and an established diagnosis.

Safety Considerations Specific to Washington Patients

Washington's climate and geography create a few practical considerations for testosterone enanthate users. The medication should be stored at controlled room temperature (68 to 77°F). During winter months in eastern Washington, where temperatures drop below freezing, avoid leaving vials in unheated spaces or vehicles, as crystallization can occur and may not fully resolve upon rewarming.

Patients in rural Washington (e.g., Okanogan County, Ferry County, the Olympic Peninsula) may face longer drives to lab draw sites. Mobile phlebotomy services now operate in many rural areas, and several telehealth TRT providers include at-home lab kits (dried blood spot or venipuncture kits) that can be mailed to a reference laboratory.

Washington's opioid and controlled substance monitoring program, the Prescription Monitoring Program (PMP), tracks all Schedule II through V dispensing. Testosterone enanthate prescriptions appear in the PMP, and prescribers are required to check the PMP before issuing or renewing controlled substance prescriptions [11]. This is a routine administrative step that does not delay prescribing for legitimate TRT patients.

A 2019 cross-sectional study of testosterone prescribing trends published in JAMA Internal Medicine found that TRT prescriptions in the United States increased 300% between 2001 and 2013, with the sharpest growth among men aged 40 to 64 [12]. Washington's prescribing volume tracked with national trends, and the availability of telehealth has further expanded access since 2020.